2,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 250mg

1,4,7,10,13-Pentaoxa-16-azacyclooctadecane, 95.0%, 100mg

(3-(Benzylthio)phenyl)boronic acid, 95.0%, 1g

GC capillary column ROTI®Cap-35 MS, 30 m, 0.25 mm, 1 Piece(s)

Methyl 6-(1-aminoethyl)nicotinate dihydrochloride, 250mg

2-Amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester, 96.0%, 1g

N-Methyl-3-(trifluoromethyl)aniline hydrochloride, 95%, 1g

rPSL1a-Biotin [for Sia alpha(2-6)Gal]1mL

(3R,4S)-1-tert-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate, 95.0%, 250mg

(2E)-1-(4-methylphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(S)-Methyl 2-aminohexanoate hydrochloride, 95.0%, 1g

2-(2-Methoxyphenyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid, 95.0%, 5g

4-(4-Methoxybenzoyl)oxane, 98%, 500mg